When your chest infection could be a sign of lung cancer - red flag signs to spot
As cold and flu season approaches, many infections can turn into chest infections; then, again, it could be cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - October 29, 2023 Category: Consumer Health News Source Type: news
Tragic minister's widow is on a cancer crusade
EXCLUSIVE: Former Norther Ireland Secretary's lung cancer diagnosis and death has led to his widow starting a campaign to promote targeted lung health checks. (Source: Daily Express - Health)
Source: Daily Express - Health - October 28, 2023 Category: Consumer Health News Source Type: news
Neoadjuvant, Adjuvant, or Both? The Debate in NSCLC Rages On Neoadjuvant, Adjuvant, or Both? The Debate in NSCLC Rages On
The question of whether to give upfront immunochemotherapy in resectable non –small cell lung cancer, wait until after surgery, or give both remains a hot topic of debate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Risk-based lung cancer screening mitigates healthcare disparities
Embargoed Until October 26, 2023 @ 8:00 am PT Risk-based lung cancer screening using a model called the PLCOm2012-Update appears to mitigate racial and ethnic disparities and improve screening performance compared to a protocol based on the USPSTF 2021 criteria, researchers have found.Why? Because the PLCOm2012-Update model takes risk of lung cancer into account, reported a team led by Eunji Choi, PhD, of Stanford University School of Medicine. The study results were published October 26 in JAMA Oncology."The findings of this study suggest that risk-based screening reduces racial and ethnic disparities while maintaining im...
Source: AuntMinnie.com Headlines - October 26, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News CT Source Type: news
Morphologic features on sonography predict metastasis
Morphologic features of axillary nodes on sonography are reliable indicators in predicting metastasis, according to research published October 24 in Clinical Imaging.
A team led by Anubha Wadhwa, MD, from Froedtert Hospital in Milwaukee, WI, found that greater cortical thickness and the absence of a normal hilum had the highest positive predictive value (PPV) for metastatic disease.
“Using clinical history in conjunction with imaging findings will help improve the accuracy of axillary nodal biopsies, especially for incidental nodes detected on screening,” the Wadhwa team wrote.
Predicting axillary nodal status is ...
Source: AuntMinnie.com Headlines - October 26, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
New Options Challenge Standard Treatments in EGFR-Mutant NSCLC
(MedPage Today) -- MADRID -- Two positive phase III trials involving amivantamab (Rybrevant)-based regimens introduced new first- and second-line options in EGFR-mutant non-small cell lung cancer (NSCLC), though toxicity with the combination... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 25, 2023 Category: Hematology Source Type: news
ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer
(MedPage Today) -- MADRID -- Disease-free survival (DFS) in resectable ALK-positive non-small cell lung cancer (NSCLC) improved by 76% with adjuvant alectinib (Alecensa) compared with chemotherapy, according to a randomized trial.
Across disease... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 24, 2023 Category: Hematology Source Type: news
Five little-known warning signs of lung cancer revealed after death of Massive Attack star Angelo Bruschini
The Bristol-born musician revealed in July that he was diagnosed with the deadly disease. Lung cancer, which kills around 35,000 Brits each year, is the second most common cancer worldwide. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2023 Category: Consumer Health News Source Type: news
Park Seo-Bo, Whose Quiet Paintings Trumpeted Korean Art, Dies at 91
Park Seo-Bo, a painter whose elegantly furrowed monochromes and indefatigable drive made him a pillar of the Korean art world, died on Oct. 14 in Seoul. He was 91. His son Park Seungho said the cause was cardiopulmonary arrest, adding that his father had chosen to forego treatment for lung cancer.…#parkseobo #korean #seoul #parkseungho #baangkentaik #écritures (Source: Reuters: Health)
Source: Reuters: Health - October 23, 2023 Category: Consumer Health News Source Type: news
Targeting KRAS in NSCLC: Recent Progress and New Approaches
(MedPage Today) -- MedPage Today brought together three expert leaders for a virtual roundtable discussion on lung cancer: Moderator Roy Herbst, MD, PhD, is joined by Anne Chiang, MD, PhD, and So Yeon Kim, MD, all from the Yale Cancer Center in... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 23, 2023 Category: Hematology Source Type: news
New First-Line Standard for Lung Cancers With EGFR Exon 20 Insertions
(MedPage Today) -- MADRID -- Amivantamab (Rybrevant) confirmed its clinical benefit in advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions, and in doing so has established a new first-line standard for this patient population... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 23, 2023 Category: Hematology Source Type: news
RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC
(MedPage Today) -- MADRID -- First-line treatment with the RET inhibitor selpercatinib (Retevmo) achieved superior outcomes in both medullary thyroid cancer (MTC) and advanced non-small cell lung cancer (NSCLC), according to results from two... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 23, 2023 Category: Hematology Source Type: news
Bi-Specific T-Cell Engager Active in Small-Cell Lung Cancer in Third Line and Beyond
(MedPage Today) -- MADRID -- Patients with previously treated small-cell lung cancer (SCLC) obtained durable responses with either of two doses of the bispecific T cell-engaging (BiTE) antibody tarlatamab, according to a study reported here.... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 22, 2023 Category: Hematology Source Type: news
Roche Taps AI to Find Lung Cancer Patients After Trial Success
(Source: Reuters: Health)
Source: Reuters: Health - October 21, 2023 Category: Consumer Health News Source Type: news
Mays Cancer Center at UT Health San Antonio identifies possible markers for early metastatic lung cancer
Research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio discovers possible early signals of metastatic lung cancer, leading to an NCI grant and pending trials that could lead to new treatment. SAN ANTONIO, Oct. 19, 2023 /PRNewswire-PRWeb/ --... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 19, 2023 Category: Pharmaceuticals Tags: TRI SVY Source Type: news
